CHARLOTTE, N.C., July 24, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Holdings Inc. (NASDAQ: AMOD), a pioneer in AI-driven retail technology, is pleased to announce a significant milestone in its ongoing commitment to long-term shareholder value. As of today, the Company confirms that all variable rate debt associated with the DESPAC process has been fully resolved and extinguished. This achievement marks the culmination of a strategic initiative that has been central to Alpha Modus’ financial philosophy over the ...

OMER, Israel, July 24, 2025 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (NASDAQ: ODYS) has completed the delivery of a vision-based monitoring system for the Heron TP UAV, a remotely piloted aircraft system ("RPAS"). The system, developed by Odysight.ai for Israel’s Ministry of Defense (MOD), provides advanced remote monitoring capabilities using unique algorithms and a miniature sensor-based optical system. The integration is designed to support improved engine health monitoring and mission assurance, tailored sp ...

SHENZHEN, China, July 24, 2025 (GLOBE NEWSWIRE) -- Skillful Craftsman Education Technology Limited (NASDAQ: EDTK), a company specializing in educational technology innovation, artificial intelligence skills training, and the digital transformation of educational institutions, announced today, it launched its communication enrichment app ’Sesame Chat’ on iOS platforms in China. The app employs proprietary AI technology to analyze communication contexts and relationship dynamics. Mr. Fu Bin, CEO of Skillful C ...

SOMERSET, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, will host a conference call on Thursday, August 7, 2025, at 5:00 p.m. Eastern Daylight Time (EDT) to discuss its financial results for the second quarter ended June 30, 2025. The Company’s results will be reported in a press release prior to the call. CompoSecure’s Executive Chairman David Cote, President & CEO Jon Wilk, and CFO Tim Fitzsimmons will hos ...

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility: Credit: Pixabay/CC0 Public Domain Tesla Inc.'s core car-making business is facing a deteriorating outlook, providing a major test of Chief Executive Officer Elon Musk's ability to lift the stock price with his vision of a self-driving future. The electric-vehicle maker is expected to post the sharpest drop in revenues in more ...

Data presented at the UMDF meeting highlighting first three of expected six subjects and two compassionate use patients provide encouraging results supporting continuation of trialHAIFA, Israel, July 24, 2025 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, announces positive interim results of the ongoing Phase 2 trial of the Company’s lead investigati ...

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Replimune Group, Inc. (NASDAQ: REPL) for potential violations of the federal securities laws. If you invested in Replimune, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/replimune-group-class-action-lawsuit. Why is Replimune being Investigated? Replimune is a clinical-stage biotechnology company focused on developin ...

KB304 designed to deliver collagen and elastin to restore skin naturally Conference call to discuss results scheduled for Thursday, July 24, 2025 at 4:30pm ET PITTSBURGH, July 24, 2025 (GLOBE NEWSWIRE) -- Jeune Aesthetics, Inc. (“Jeune”), a wholly owned subsidiary of Krystal Biotech, Inc. (“Krystal”) (NASDAQ: KRYS) leveraging Krystal’s clinically validated gene-delivery platform to fundamentally reverse the biology of aging skin, announced today positive safety and efficacy results, including significant im ...

EMERYVILLE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced podium presentations at the 43rd Annual Scientific Meeting of the American Society of Retina Specialists (ASRS) being held in Long Beach, CA, from July 30 – August 2, 2025. ASRS 2025 Prese ...

SAN DIEGO, July 24, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that it will report its second quarter 2025 financial results and operational highlights after the close of the U.S. financial markets on Thursday, August 7, 2025. The Company will host a conference call and webcast at 5:00 PM Eastern Time to discuss the results and provide an update on bu ...